Skip to main content
. 2015 Sep 17;10(9):e0137904. doi: 10.1371/journal.pone.0137904

Fig 6. Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.

Fig 6